Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.

Seminars in respiratory and critical care medicine - 1 Apr 2015

Barry Peter J, Ronan Nicola, Plant Barry J

Abstract excerpt

Cystic fibrosis (CF) represents one of the success stories of modern medicine with sustained incremental increases in the survival from one of childhood death to one of adult survival into the middle decades over the past 30 years. Improving survival has focused on multidisciplinary management centered on treating the consequences of this genetic disease. It has been firmly established for more than 20 years that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CFTR gene

Share to Genetic Therapy

Share to Mutation

Source

Identifiers

PMID: 25826594
DOI: 10.1055/s-0035-1546821

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.PMID 25826594Read ↗

Discovery of CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

Toward inclusive therapy with CFTR modulators: Progress and challengesSemantic proximity Read ↗

Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic Fibrosis.Semantic proximity Read ↗

CFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisSemantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesSemantic proximity Read ↗

Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR.Semantic proximity Read ↗

CFTR Modulators: From Mechanism to Targeted Therapeutics.Semantic proximity Read ↗

Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.Semantic proximity Read ↗

New Therapies to Correct the Cystic Fibrosis Basic Defect.Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosisSemantic proximity Read ↗

Ion Channel Modulators in Cystic Fibrosis.Semantic proximity Read ↗

Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.